Evidence map›Paper›PMID 25848053›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

General and condition-specific essential functions of Pseudomonas aeruginosa.

Samuel A Lee, Larry A Gallagher, Metawee Thongdee, Benjamin J Staudinger, Soyeon Lippman, Pradeep K Singh, Colin Manoil

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 121 papers.

0numbers the graph read from it
0cells of the map it votes in
121citing papers in PubMed
14.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

121 citing papers in PubMed, 193 citations in OpenAlex.

  1. Article
  2. Distinctive Lacritin Cleavage-Potentiated Bactericidal Alteration of thebioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Architecture ofProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

61 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Samuel A LeeDepartment of Genome Sciences and.
Larry A GallagherDepartment of Genome Sciences and.
Metawee ThongdeeCenter for Zoonotic Diseases, Faculty of Veterinary Science, Mahidol University, 73170 Bangkok, Thailand.
Benjamin J StaudingerDepartment of Microbiology and Medicine, University of Washington, Seattle, WA 98195; and.
Soyeon LippmanDepartment of Genome Sciences and.
Pradeep K SinghDepartment of Microbiology and Medicine, University of Washington, Seattle, WA 98195; and.
Colin ManoilDepartment of Genome Sciences and manoil@u.washington.edu.
Human Genome Sciences (United States) · USUniversity of Washington · USMahidol University · TH

Funding

Translational Research Center to Expedite Novel Therapies in Cystic FibrosisP30DK089507 · NIDDK · SEATTLE CHILDREN'S HOSPITAL · PI Christopher Hooper Goss, Lucas R Hoffman · 2010 to 2026
$21.4M
Investigating treatment resistance mechanisms in chronic bacterial infectionsR01AI101307 · NIAID · UNIVERSITY OF WASHINGTON · PI BRUCE, JAMES EDWARD, MANOIL, COLIN · 2012 to 2016
$2.9M
Studies on bacterial populations and therapeutics for CF lung infectionsK24HL102246 · NHLBI · UNIVERSITY OF WASHINGTON · PI SINGH, PRADEEP K · 2010 to 2019
$1.6M
Investigating bacterial-host interactions driving CF Pulmonary ExacerbationsR01HL110879 · NHLBI · UNIVERSITY OF WASHINGTON · PI BRUCE, JAMES EDWARD, SINGH, PRADEEP K · 2011 to 2014
$1.6M
Targeting chronic Pseudomonas aeruginosa wound infectionsR21AI105898 · NIAID · UNIVERSITY OF WASHINGTON · PI MANOIL, COLIN · 2013 to 2014
$420k
NHLBI NIH HHS K24 HL102246NHLBI NIH HHS R01 HL110879NHLBI NIH HHS R01HL110879NIAID NIH HHS 1 R21 AI105898NIAID NIH HHS R01 AI101307NIAID NIH HHS R01AI101307NIAID NIH HHS R21 AI105898NIDDK NIH HHS P30 DK089507
6 · The paper itself

Abstract

The essential functions of a bacterial pathogen reflect the most basic processes required for its viability and growth, and represent potential therapeutic targets. Most screens for essential genes have assayed a single condition--growth in a rich undefined medium--and thus have not distinguished genes that are generally essential from those that are specific to this particular condition. To help define these classes for Pseudomonas aeruginosa, we identified genes required for growth on six different media, including a medium made from cystic fibrosis patient sputum. The analysis used the Tn-seq circle method to achieve high genome coverage and analyzed more than 1,000,000 unique insertion positions (an average of one insertion every 6.0 bp). We identified 352 general and 199 condition-specific essential genes. A subset of assignments was verified in individual strains with regulated expression alleles. The profile of essential genes revealed that, compared with Escherichia coli, P. aeruginosa is highly vulnerable to mutations disrupting central carbon-energy metabolism and reactive oxygen defenses. These vulnerabilities may arise from the stripped-down architecture of the organism's carbohydrate utilization pathways and its reliance on respiration for energy generation. The essential function profile thus provides fundamental insights into P. aeruginosa physiology as well as identifying candidate targets for new antibacterial agents.

Indexed as

CarbonDNA Transposable ElementsEscherichia coliGenes, BacterialGenes, EssentialMutagenesis, InsertionalPhylogenyPseudomonas aeruginosaCarbonDNA Transposable Elementsantibiotic targetcystic fibrosisESKAPEsputumTn-seq

Identifiers

PMID25848053
PMCPMC4413342
OpenAlexW2073573730

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.